nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—CYP2C18—Ifosfamide—testicular cancer	0.652	0.736	CbGbCtD
Vilazodone—CYP3A4—Ifosfamide—testicular cancer	0.0633	0.0716	CbGbCtD
Vilazodone—CYP2D6—Vinblastine—testicular cancer	0.0528	0.0597	CbGbCtD
Vilazodone—CYP3A4—Vinblastine—testicular cancer	0.0336	0.038	CbGbCtD
Vilazodone—CYP2D6—Doxorubicin—testicular cancer	0.0325	0.0367	CbGbCtD
Vilazodone—CYP3A4—Etoposide—testicular cancer	0.0303	0.0342	CbGbCtD
Vilazodone—CYP3A4—Doxorubicin—testicular cancer	0.0206	0.0233	CbGbCtD
Vilazodone—Panic attack—Ifosfamide—testicular cancer	0.00489	0.0424	CcSEcCtD
Vilazodone—Mania—Ifosfamide—testicular cancer	0.00251	0.0217	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Ifosfamide—testicular cancer	0.00202	0.0175	CcSEcCtD
Vilazodone—Hallucination—Chlorambucil—testicular cancer	0.00138	0.0119	CcSEcCtD
Vilazodone—Breast disorder—Ifosfamide—testicular cancer	0.0012	0.0104	CcSEcCtD
Vilazodone—Hyponatraemia—Cisplatin—testicular cancer	0.00114	0.00992	CcSEcCtD
Vilazodone—Tremor—Chlorambucil—testicular cancer	0.00113	0.00978	CcSEcCtD
Vilazodone—Agitation—Chlorambucil—testicular cancer	0.00111	0.00959	CcSEcCtD
Vilazodone—Irritability—Cisplatin—testicular cancer	0.00109	0.00943	CcSEcCtD
Vilazodone—Pollakiuria—Ifosfamide—testicular cancer	0.00106	0.00915	CcSEcCtD
Vilazodone—Convulsion—Chlorambucil—testicular cancer	0.00104	0.00904	CcSEcCtD
Vilazodone—Breast disorder—Cisplatin—testicular cancer	0.00103	0.00893	CcSEcCtD
Vilazodone—Convulsion—Vinblastine—testicular cancer	0.000956	0.00829	CcSEcCtD
Vilazodone—Hallucination—Ifosfamide—testicular cancer	0.00091	0.00789	CcSEcCtD
Vilazodone—Connective tissue disorder—Ifosfamide—testicular cancer	0.000899	0.00779	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Epirubicin—testicular cancer	0.000893	0.00774	CcSEcCtD
Vilazodone—Dyspepsia—Chlorambucil—testicular cancer	0.000865	0.0075	CcSEcCtD
Vilazodone—Eye disorder—Ifosfamide—testicular cancer	0.000855	0.00741	CcSEcCtD
Vilazodone—Decreased appetite—Chlorambucil—testicular cancer	0.000854	0.00741	CcSEcCtD
Vilazodone—Cardiac disorder—Ifosfamide—testicular cancer	0.000849	0.00736	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000848	0.00735	CcSEcCtD
Vilazodone—Fatigue—Chlorambucil—testicular cancer	0.000847	0.00734	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Doxorubicin—testicular cancer	0.000826	0.00716	CcSEcCtD
Vilazodone—Feeling abnormal—Chlorambucil—testicular cancer	0.00081	0.00702	CcSEcCtD
Vilazodone—Paraesthesia—Vinblastine—testicular cancer	0.000809	0.00701	CcSEcCtD
Vilazodone—Mental disorder—Ifosfamide—testicular cancer	0.000802	0.00695	CcSEcCtD
Vilazodone—Abnormal dreams—Epirubicin—testicular cancer	0.000797	0.00691	CcSEcCtD
Vilazodone—Malnutrition—Ifosfamide—testicular cancer	0.000797	0.0069	CcSEcCtD
Vilazodone—Decreased appetite—Vinblastine—testicular cancer	0.000783	0.00679	CcSEcCtD
Vilazodone—Connective tissue disorder—Cisplatin—testicular cancer	0.000775	0.00672	CcSEcCtD
Vilazodone—Vision blurred—Ifosfamide—testicular cancer	0.000751	0.00651	CcSEcCtD
Vilazodone—Dry eye—Epirubicin—testicular cancer	0.000745	0.00646	CcSEcCtD
Vilazodone—Feeling abnormal—Vinblastine—testicular cancer	0.000742	0.00643	CcSEcCtD
Vilazodone—Abnormal dreams—Doxorubicin—testicular cancer	0.000738	0.00639	CcSEcCtD
Vilazodone—Eye disorder—Cisplatin—testicular cancer	0.000737	0.00639	CcSEcCtD
Vilazodone—Cardiac disorder—Cisplatin—testicular cancer	0.000732	0.00635	CcSEcCtD
Vilazodone—Agitation—Ifosfamide—testicular cancer	0.000732	0.00634	CcSEcCtD
Vilazodone—Asthenia—Chlorambucil—testicular cancer	0.000705	0.00611	CcSEcCtD
Vilazodone—Palpitations—Ifosfamide—testicular cancer	0.000704	0.0061	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000693	0.00601	CcSEcCtD
Vilazodone—Convulsion—Ifosfamide—testicular cancer	0.00069	0.00598	CcSEcCtD
Vilazodone—Dry eye—Doxorubicin—testicular cancer	0.000689	0.00598	CcSEcCtD
Vilazodone—Malnutrition—Cisplatin—testicular cancer	0.000687	0.00595	CcSEcCtD
Vilazodone—Paraesthesia—Bleomycin—testicular cancer	0.000683	0.00592	CcSEcCtD
Vilazodone—Arthralgia—Ifosfamide—testicular cancer	0.000678	0.00588	CcSEcCtD
Vilazodone—Flatulence—Cisplatin—testicular cancer	0.000677	0.00587	CcSEcCtD
Vilazodone—Eye disorder—Etoposide—testicular cancer	0.000675	0.00585	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000673	0.00584	CcSEcCtD
Vilazodone—Diarrhoea—Chlorambucil—testicular cancer	0.000672	0.00583	CcSEcCtD
Vilazodone—Cardiac disorder—Etoposide—testicular cancer	0.000671	0.00581	CcSEcCtD
Vilazodone—Decreased appetite—Bleomycin—testicular cancer	0.000661	0.00573	CcSEcCtD
Vilazodone—Vision blurred—Cisplatin—testicular cancer	0.000647	0.00561	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000646	0.0056	CcSEcCtD
Vilazodone—Asthenia—Vinblastine—testicular cancer	0.000646	0.0056	CcSEcCtD
Vilazodone—Tremor—Cisplatin—testicular cancer	0.000643	0.00558	CcSEcCtD
Vilazodone—Nervous system disorder—Ifosfamide—testicular cancer	0.000638	0.00553	CcSEcCtD
Vilazodone—Skin disorder—Ifosfamide—testicular cancer	0.000631	0.00547	CcSEcCtD
Vilazodone—Hyperhidrosis—Ifosfamide—testicular cancer	0.000628	0.00545	CcSEcCtD
Vilazodone—Feeling abnormal—Bleomycin—testicular cancer	0.000627	0.00543	CcSEcCtD
Vilazodone—Vomiting—Chlorambucil—testicular cancer	0.000625	0.00542	CcSEcCtD
Vilazodone—Increased appetite—Epirubicin—testicular cancer	0.000623	0.0054	CcSEcCtD
Vilazodone—Decreased appetite—Dactinomycin—testicular cancer	0.000617	0.00535	CcSEcCtD
Vilazodone—Diarrhoea—Vinblastine—testicular cancer	0.000616	0.00534	CcSEcCtD
Vilazodone—Dysgeusia—Etoposide—testicular cancer	0.000616	0.00534	CcSEcCtD
Vilazodone—Fatigue—Dactinomycin—testicular cancer	0.000612	0.0053	CcSEcCtD
Vilazodone—Irritability—Methotrexate—testicular cancer	0.000597	0.00518	CcSEcCtD
Vilazodone—Dizziness—Vinblastine—testicular cancer	0.000596	0.00516	CcSEcCtD
Vilazodone—Convulsion—Cisplatin—testicular cancer	0.000595	0.00516	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000592	0.00513	CcSEcCtD
Vilazodone—Hyponatraemia—Epirubicin—testicular cancer	0.000588	0.0051	CcSEcCtD
Vilazodone—Feeling abnormal—Dactinomycin—testicular cancer	0.000585	0.00507	CcSEcCtD
Vilazodone—Nausea—Chlorambucil—testicular cancer	0.000584	0.00506	CcSEcCtD
Vilazodone—Paraesthesia—Ifosfamide—testicular cancer	0.000584	0.00506	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000581	0.00503	CcSEcCtD
Vilazodone—Somnolence—Ifosfamide—testicular cancer	0.000578	0.00501	CcSEcCtD
Vilazodone—Increased appetite—Doxorubicin—testicular cancer	0.000577	0.005	CcSEcCtD
Vilazodone—Migraine—Epirubicin—testicular cancer	0.000576	0.005	CcSEcCtD
Vilazodone—Vomiting—Vinblastine—testicular cancer	0.000573	0.00496	CcSEcCtD
Vilazodone—Breast disorder—Methotrexate—testicular cancer	0.000565	0.0049	CcSEcCtD
Vilazodone—Decreased appetite—Ifosfamide—testicular cancer	0.000565	0.0049	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000561	0.00486	CcSEcCtD
Vilazodone—Fatigue—Ifosfamide—testicular cancer	0.00056	0.00486	CcSEcCtD
Vilazodone—Nervous system disorder—Cisplatin—testicular cancer	0.00055	0.00476	CcSEcCtD
Vilazodone—Asthenia—Bleomycin—testicular cancer	0.000546	0.00473	CcSEcCtD
Vilazodone—Convulsion—Etoposide—testicular cancer	0.000545	0.00472	CcSEcCtD
Vilazodone—Skin disorder—Cisplatin—testicular cancer	0.000544	0.00472	CcSEcCtD
Vilazodone—Hyponatraemia—Doxorubicin—testicular cancer	0.000544	0.00472	CcSEcCtD
Vilazodone—Hyperhidrosis—Cisplatin—testicular cancer	0.000542	0.0047	CcSEcCtD
Vilazodone—Feeling abnormal—Ifosfamide—testicular cancer	0.000536	0.00464	CcSEcCtD
Vilazodone—Nausea—Vinblastine—testicular cancer	0.000535	0.00464	CcSEcCtD
Vilazodone—Migraine—Doxorubicin—testicular cancer	0.000533	0.00462	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000532	0.00461	CcSEcCtD
Vilazodone—Breast disorder—Epirubicin—testicular cancer	0.000529	0.00459	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000511	0.00443	CcSEcCtD
Vilazodone—Asthenia—Dactinomycin—testicular cancer	0.000509	0.00441	CcSEcCtD
Vilazodone—Paraesthesia—Cisplatin—testicular cancer	0.000503	0.00436	CcSEcCtD
Vilazodone—Skin disorder—Etoposide—testicular cancer	0.000499	0.00432	CcSEcCtD
Vilazodone—Erectile dysfunction—Methotrexate—testicular cancer	0.000498	0.00432	CcSEcCtD
Vilazodone—Hyperhidrosis—Etoposide—testicular cancer	0.000496	0.0043	CcSEcCtD
Vilazodone—Breast disorder—Doxorubicin—testicular cancer	0.00049	0.00424	CcSEcCtD
Vilazodone—Decreased appetite—Cisplatin—testicular cancer	0.000487	0.00422	CcSEcCtD
Vilazodone—Diarrhoea—Dactinomycin—testicular cancer	0.000485	0.00421	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000484	0.00419	CcSEcCtD
Vilazodone—Vomiting—Bleomycin—testicular cancer	0.000484	0.00419	CcSEcCtD
Vilazodone—Pollakiuria—Epirubicin—testicular cancer	0.000468	0.00405	CcSEcCtD
Vilazodone—Asthenia—Ifosfamide—testicular cancer	0.000466	0.00404	CcSEcCtD
Vilazodone—Feeling abnormal—Cisplatin—testicular cancer	0.000462	0.004	CcSEcCtD
Vilazodone—Paraesthesia—Etoposide—testicular cancer	0.000461	0.004	CcSEcCtD
Vilazodone—Somnolence—Etoposide—testicular cancer	0.000456	0.00396	CcSEcCtD
Vilazodone—Nausea—Bleomycin—testicular cancer	0.000452	0.00392	CcSEcCtD
Vilazodone—Vomiting—Dactinomycin—testicular cancer	0.000451	0.00391	CcSEcCtD
Vilazodone—Decreased appetite—Etoposide—testicular cancer	0.000446	0.00387	CcSEcCtD
Vilazodone—Diarrhoea—Ifosfamide—testicular cancer	0.000445	0.00386	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000443	0.00384	CcSEcCtD
Vilazodone—Fatigue—Etoposide—testicular cancer	0.000443	0.00384	CcSEcCtD
Vilazodone—Pollakiuria—Doxorubicin—testicular cancer	0.000433	0.00375	CcSEcCtD
Vilazodone—Dizziness—Ifosfamide—testicular cancer	0.00043	0.00373	CcSEcCtD
Vilazodone—Feeling abnormal—Etoposide—testicular cancer	0.000423	0.00367	CcSEcCtD
Vilazodone—Nausea—Dactinomycin—testicular cancer	0.000421	0.00365	CcSEcCtD
Vilazodone—Vomiting—Ifosfamide—testicular cancer	0.000413	0.00358	CcSEcCtD
Vilazodone—Eye disorder—Methotrexate—testicular cancer	0.000405	0.00351	CcSEcCtD
Vilazodone—Asthenia—Cisplatin—testicular cancer	0.000402	0.00349	CcSEcCtD
Vilazodone—Cardiac disorder—Methotrexate—testicular cancer	0.000402	0.00348	CcSEcCtD
Vilazodone—Connective tissue disorder—Epirubicin—testicular cancer	0.000398	0.00345	CcSEcCtD
Vilazodone—Nausea—Ifosfamide—testicular cancer	0.000386	0.00335	CcSEcCtD
Vilazodone—Diarrhoea—Cisplatin—testicular cancer	0.000383	0.00332	CcSEcCtD
Vilazodone—Mental disorder—Methotrexate—testicular cancer	0.000379	0.00329	CcSEcCtD
Vilazodone—Eye disorder—Epirubicin—testicular cancer	0.000379	0.00328	CcSEcCtD
Vilazodone—Malnutrition—Methotrexate—testicular cancer	0.000377	0.00327	CcSEcCtD
Vilazodone—Cardiac disorder—Epirubicin—testicular cancer	0.000376	0.00326	CcSEcCtD
Vilazodone—Dysgeusia—Methotrexate—testicular cancer	0.000369	0.0032	CcSEcCtD
Vilazodone—Asthenia—Etoposide—testicular cancer	0.000368	0.00319	CcSEcCtD
Vilazodone—Connective tissue disorder—Doxorubicin—testicular cancer	0.000368	0.00319	CcSEcCtD
Vilazodone—Vomiting—Cisplatin—testicular cancer	0.000356	0.00309	CcSEcCtD
Vilazodone—Vision blurred—Methotrexate—testicular cancer	0.000355	0.00308	CcSEcCtD
Vilazodone—Mental disorder—Epirubicin—testicular cancer	0.000355	0.00308	CcSEcCtD
Vilazodone—Malnutrition—Epirubicin—testicular cancer	0.000353	0.00306	CcSEcCtD
Vilazodone—Diarrhoea—Etoposide—testicular cancer	0.000351	0.00304	CcSEcCtD
Vilazodone—Eye disorder—Doxorubicin—testicular cancer	0.00035	0.00304	CcSEcCtD
Vilazodone—Cardiac disorder—Doxorubicin—testicular cancer	0.000348	0.00302	CcSEcCtD
Vilazodone—Flatulence—Epirubicin—testicular cancer	0.000347	0.00301	CcSEcCtD
Vilazodone—Dysgeusia—Epirubicin—testicular cancer	0.000345	0.00299	CcSEcCtD
Vilazodone—Nervousness—Epirubicin—testicular cancer	0.000343	0.00297	CcSEcCtD
Vilazodone—Dizziness—Etoposide—testicular cancer	0.00034	0.00294	CcSEcCtD
Vilazodone—Nausea—Cisplatin—testicular cancer	0.000333	0.00289	CcSEcCtD
Vilazodone—Vision blurred—Epirubicin—testicular cancer	0.000332	0.00288	CcSEcCtD
Vilazodone—Mental disorder—Doxorubicin—testicular cancer	0.000328	0.00285	CcSEcCtD
Vilazodone—Convulsion—Methotrexate—testicular cancer	0.000326	0.00283	CcSEcCtD
Vilazodone—Vomiting—Etoposide—testicular cancer	0.000326	0.00283	CcSEcCtD
Vilazodone—Malnutrition—Doxorubicin—testicular cancer	0.000326	0.00283	CcSEcCtD
Vilazodone—Agitation—Epirubicin—testicular cancer	0.000324	0.00281	CcSEcCtD
Vilazodone—Flatulence—Doxorubicin—testicular cancer	0.000322	0.00279	CcSEcCtD
Vilazodone—Arthralgia—Methotrexate—testicular cancer	0.000321	0.00278	CcSEcCtD
Vilazodone—Dysgeusia—Doxorubicin—testicular cancer	0.00032	0.00277	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000319	0.00276	CcSEcCtD
Vilazodone—Nervousness—Doxorubicin—testicular cancer	0.000317	0.00275	CcSEcCtD
Vilazodone—Palpitations—Epirubicin—testicular cancer	0.000312	0.0027	CcSEcCtD
Vilazodone—Vision blurred—Doxorubicin—testicular cancer	0.000308	0.00267	CcSEcCtD
Vilazodone—Convulsion—Epirubicin—testicular cancer	0.000306	0.00265	CcSEcCtD
Vilazodone—Nausea—Etoposide—testicular cancer	0.000305	0.00264	CcSEcCtD
Vilazodone—Nervous system disorder—Methotrexate—testicular cancer	0.000302	0.00261	CcSEcCtD
Vilazodone—Arthralgia—Epirubicin—testicular cancer	0.0003	0.0026	CcSEcCtD
Vilazodone—Agitation—Doxorubicin—testicular cancer	0.0003	0.0026	CcSEcCtD
Vilazodone—Skin disorder—Methotrexate—testicular cancer	0.000299	0.00259	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000298	0.00258	CcSEcCtD
Vilazodone—Hyperhidrosis—Methotrexate—testicular cancer	0.000297	0.00258	CcSEcCtD
Vilazodone—Dry mouth—Epirubicin—testicular cancer	0.000294	0.00255	CcSEcCtD
Vilazodone—Palpitations—Doxorubicin—testicular cancer	0.000288	0.0025	CcSEcCtD
Vilazodone—Convulsion—Doxorubicin—testicular cancer	0.000283	0.00245	CcSEcCtD
Vilazodone—Nervous system disorder—Epirubicin—testicular cancer	0.000282	0.00245	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00028	0.00243	CcSEcCtD
Vilazodone—Skin disorder—Epirubicin—testicular cancer	0.00028	0.00242	CcSEcCtD
Vilazodone—Hyperhidrosis—Epirubicin—testicular cancer	0.000278	0.00241	CcSEcCtD
Vilazodone—Insomnia—Methotrexate—testicular cancer	0.000278	0.00241	CcSEcCtD
Vilazodone—Arthralgia—Doxorubicin—testicular cancer	0.000278	0.00241	CcSEcCtD
Vilazodone—Paraesthesia—Methotrexate—testicular cancer	0.000276	0.00239	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000276	0.00239	CcSEcCtD
Vilazodone—Somnolence—Methotrexate—testicular cancer	0.000273	0.00237	CcSEcCtD
Vilazodone—Dry mouth—Doxorubicin—testicular cancer	0.000272	0.00235	CcSEcCtD
Vilazodone—Dyspepsia—Methotrexate—testicular cancer	0.000271	0.00235	CcSEcCtD
Vilazodone—Decreased appetite—Methotrexate—testicular cancer	0.000267	0.00232	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000266	0.0023	CcSEcCtD
Vilazodone—Fatigue—Methotrexate—testicular cancer	0.000265	0.0023	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000262	0.00227	CcSEcCtD
Vilazodone—Nervous system disorder—Doxorubicin—testicular cancer	0.000261	0.00226	CcSEcCtD
Vilazodone—Insomnia—Epirubicin—testicular cancer	0.00026	0.00226	CcSEcCtD
Vilazodone—Skin disorder—Doxorubicin—testicular cancer	0.000259	0.00224	CcSEcCtD
Vilazodone—Paraesthesia—Epirubicin—testicular cancer	0.000258	0.00224	CcSEcCtD
Vilazodone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000257	0.00223	CcSEcCtD
Vilazodone—Somnolence—Epirubicin—testicular cancer	0.000256	0.00222	CcSEcCtD
Vilazodone—Feeling abnormal—Methotrexate—testicular cancer	0.000253	0.0022	CcSEcCtD
Vilazodone—Dyspepsia—Epirubicin—testicular cancer	0.000253	0.0022	CcSEcCtD
Vilazodone—Decreased appetite—Epirubicin—testicular cancer	0.00025	0.00217	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000248	0.00215	CcSEcCtD
Vilazodone—Fatigue—Epirubicin—testicular cancer	0.000248	0.00215	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000243	0.0021	CcSEcCtD
Vilazodone—Insomnia—Doxorubicin—testicular cancer	0.000241	0.00209	CcSEcCtD
Vilazodone—Paraesthesia—Doxorubicin—testicular cancer	0.000239	0.00207	CcSEcCtD
Vilazodone—Feeling abnormal—Epirubicin—testicular cancer	0.000237	0.00206	CcSEcCtD
Vilazodone—Somnolence—Doxorubicin—testicular cancer	0.000237	0.00205	CcSEcCtD
Vilazodone—Dyspepsia—Doxorubicin—testicular cancer	0.000234	0.00203	CcSEcCtD
Vilazodone—Decreased appetite—Doxorubicin—testicular cancer	0.000231	0.00201	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00023	0.00199	CcSEcCtD
Vilazodone—Fatigue—Doxorubicin—testicular cancer	0.00023	0.00199	CcSEcCtD
Vilazodone—Asthenia—Methotrexate—testicular cancer	0.000221	0.00191	CcSEcCtD
Vilazodone—Feeling abnormal—Doxorubicin—testicular cancer	0.000219	0.0019	CcSEcCtD
Vilazodone—Diarrhoea—Methotrexate—testicular cancer	0.00021	0.00182	CcSEcCtD
Vilazodone—Asthenia—Epirubicin—testicular cancer	0.000206	0.00179	CcSEcCtD
Vilazodone—Dizziness—Methotrexate—testicular cancer	0.000203	0.00176	CcSEcCtD
Vilazodone—Diarrhoea—Epirubicin—testicular cancer	0.000197	0.00171	CcSEcCtD
Vilazodone—Vomiting—Methotrexate—testicular cancer	0.000196	0.00169	CcSEcCtD
Vilazodone—Asthenia—Doxorubicin—testicular cancer	0.000191	0.00166	CcSEcCtD
Vilazodone—Dizziness—Epirubicin—testicular cancer	0.00019	0.00165	CcSEcCtD
Vilazodone—Vomiting—Epirubicin—testicular cancer	0.000183	0.00159	CcSEcCtD
Vilazodone—Nausea—Methotrexate—testicular cancer	0.000183	0.00158	CcSEcCtD
Vilazodone—Diarrhoea—Doxorubicin—testicular cancer	0.000182	0.00158	CcSEcCtD
Vilazodone—Dizziness—Doxorubicin—testicular cancer	0.000176	0.00153	CcSEcCtD
Vilazodone—Nausea—Epirubicin—testicular cancer	0.000171	0.00148	CcSEcCtD
Vilazodone—Vomiting—Doxorubicin—testicular cancer	0.000169	0.00147	CcSEcCtD
Vilazodone—Nausea—Doxorubicin—testicular cancer	0.000158	0.00137	CcSEcCtD
